These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35449229)

  • 1. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD.
    Perdomo CM; Ezponda A; Núñez-Córdoba JM; Herrero JI; Bastarrika G; Frühbeck G; Escalada J
    Sci Rep; 2022 Apr; 12(1):6564. PubMed ID: 35449229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
    Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.
    Mangla N; Ajmera VH; Caussy C; Sirlin C; Brouha S; Bajwa-Dulai S; Madamba E; Bettencourt R; Richards L; Loomba R
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):744-746.e1. PubMed ID: 31100460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification.
    You SC; Kim KJ; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1536-42. PubMed ID: 25973647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis.
    Liu B; Li Y; Li Y; Liu Y; Yan Y; Luo A; Ren H; She Q
    Hepatol Int; 2019 Nov; 13(6):757-765. PubMed ID: 31432447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
    Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental diagnostic value of epicardial adipose tissue for the detection of functionally relevant coronary artery disease.
    Romijn MA; Danad I; Bakkum MJ; Stuijfzand WJ; Tulevski II; Somsen GA; Lammertsma AA; van Kuijk C; van de Ven PM; Min JK; Leipsic J; van Rossum AC; Raijmakers PG; Knaapen P
    Atherosclerosis; 2015 Sep; 242(1):161-6. PubMed ID: 26188540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
    Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
    Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese.
    Ooi GJ; Mgaieth S; Eslick GD; Burton PR; Kemp WW; Roberts SK; Brown WA
    Obes Rev; 2018 Feb; 19(2):281-294. PubMed ID: 29119725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease.
    Kashiwagi K; Yamaguchi A; Shiba S; Taniki N; Inoue N; Takaishi H; Iwao Y; Kanai T
    Alcohol; 2020 Dec; 89():1-7. PubMed ID: 32738385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients.
    Guaraldi G; Scaglioni R; Zona S; Orlando G; Carli F; Ligabue G; Besutti G; Bagni P; Rossi R; Modena MG; Raggi P
    AIDS; 2011 Jun; 25(9):1199-205. PubMed ID: 21505301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    Shimizu M; Suzuki K; Kato K; Jojima T; Iijima T; Murohisa T; Iijima M; Takekawa H; Usui I; Hiraishi H; Aso Y
    Diabetes Obes Metab; 2019 Feb; 21(2):285-292. PubMed ID: 30178600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
    Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
    Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.